|
Velos Unveils Major Release of Velos Transplant
San Francisco, CA - April 17,
2003 - Velos, an innovative healthcare software and internet
services vendor, today announced Release 3.1 of Velos Transplant.
Release 3.1 includes a variety of major new features and subsystems,
including powerful additions to Velos’ “ad hoc” reporting; a major
new, fully automated UNOS management subsystem; a heart and lung
subsystem, image management, and numerous other reporting and
analysis capabilities. In addition, Velos implemented a new “go
live” methodology that enables customers to go into production the
day after data migration!
Christie Stepp, Velos customer who
heads the Velos Transplant User Group, notes: “Velos made
substantial product improvements over the course of the past year
and has been very responsive to the Velos Transplant User Group. The
new modules and features they’ve implemented are great and our new
ad hoc reporting and analysis capabilities are awesome.”
John
McIlwain, President and CEO, summarizes: “In Summer 2001, we made
transplant a top priority and put a team in place to get the job
done, in partnership with our customers. That investment has really
paid off --- Christie and her team are well ahead of most transplant
centers today in their use clinical information technology and spent
far less money getting there.”
Christie Stepp continues, “We
just implemented the heart and lung module. We converted over 40
source files, with tens of thousands of patient, lab, medication,
and other historical records. Velos came in over the weekend,
migrated information current as of the close of services Friday, and
we went into production on Monday without missing a beat. And the
data was near perfect! It’s been a tremendous
experience.”
About Velos
Velos is a leading designer and developer of next-generation healthcare information
systems. Velos develops, markets, and supports an integrated suite
of clinical, administrative, and financial products. Velos’ internet
services and turnkey solutions serve the needs of specialty
healthcare providers and clinical researchers. Over 100 healthcare
organizations use the Velos Specialty product line today. Velos is
privately held with headquarters in Silicon Valley.
This press release may contain forward-looking statements that
are subject to risks and uncertainties that could cause actual
results to differ materially from those set forth in the
forward-looking statements.
Additional information regarding
Velos eResearch may be obtained by contacting Madalynne Chapman
(510-580-2661 / mchapman@velos.com) or visit http://www.velos.com/.
|
